| 價(jià)格 | ¥289 | ¥723 | ¥1080 |
| 包裝 | 1mg | 5mg | 10mg |
| 最小起訂量 | 1mg |
| 發(fā)貨地 | 上海 |
| 更新日期 | 2026-06-29 |
| 中文名稱:CWI1-2鹽酸鹽 | 英文名稱:CWI1-2 HCL |
| CAS:2408590-37-2 | 品牌: TargetMol |
| 產(chǎn)地: 美國(guó) | 保存條件: Keep away from moisture, Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 純度規(guī)格: 99.18% | 產(chǎn)品類別: 抑制劑 |
| 貨號(hào): T001|T67930L |
| 名稱 | CWI1-2 HCL |
| 描述 | CWI1-2 HCL is an effective IGF2BP2 inhibitor, which can induce apoptosis and differentiation by binding IGF2BP2 and inhibiting its interaction with M6A-modified target transcription, and has therapeutic effects on leukemia. |
| 體外活性 | CWI1-2(0-1μM,24小時(shí)) hydrochloride 顯示出顯著的抗白血病效果。[1] |
| 體內(nèi)活性 | CWI1-2(5 mg/kg,靜脈注射,每天一次,連續(xù)7至10天) hydrochloride 在B6.SJL(CD45.1)小鼠BMT接受者中顯著延遲白血病的發(fā)病時(shí)間并延長(zhǎng)存活時(shí)間,同時(shí)對(duì)體重?zé)o顯著影響。[1] |
| 存儲(chǔ)條件 | Keep away from moisture, Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度 | 10% DMSO+90% Corn oil : 10 mg/mL (17.98 mM), Solution. 10% DMSO+90% Saline : < 10 mg/mL (17.98 mM), Lower concentrations may be soluble, but exact solubility limit is unknown. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : < 10 mg/mL (17.98 mM), Lower concentrations may be soluble, but exact solubility limit is unknown. 10% DMSO+90% (20% SBE-β-CD in Saline) : < 10 mg/mL (17.98 mM), Lower concentrations may be soluble, but exact solubility limit is unknown. DMSO : 145 mg/mL (260.68 mM), Sonication is recommended. 10% DMSO+40% PEG300+5% Tween-80+45% Saline : 1 mg/mL (1.8 mM), Sonication is recommended. |
| 關(guān)鍵字 | CWI12HCL | CWI1-2 HCL | Apoptosis |
| 相關(guān)產(chǎn)品 | Formamide | Urea | Sodium Molybdate | Dimethyl phthalate | Aceglutamide | Alginic acid | Cysteamine hydrochloride | Metronidazole | Sildenafil citrate | Citric Acid Triammonium | Stavudine | Tamoxifen |
| 相關(guān)庫 | 抑制劑庫 | 經(jīng)典已知活性庫 | 已知活性化合物庫 | 細(xì)胞凋亡化合物庫 | 血液病分子庫 |
| 成立日期 | 2013-04-18 (14年) | 注冊(cè)資本 | 566.265100萬人民幣 |
| 員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
| 主營(yíng)行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學(xué),分子砌塊,生物技術(shù)服務(wù) | 經(jīng)營(yíng)模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
| 產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
|---|---|---|---|---|
| 詢價(jià) |
VIP4年
|
唐緣生命科學(xué)(上海)有限公司
|
2026-07-28 | |
| 詢價(jià) |
VIP6年
|
武漢華玖醫(yī)藥科技有限公司
|
2026-07-29 | |
| 詢價(jià) |
VIP4年
|
湖北麗都新材料科技有限公司
|
2026-07-29 |